...
首页> 外文期刊>Materials science & engineering, C. Materials for Biogical applications >Surface modification of biomaterials based on high-molecular polylactic acid and their effect on inflammatory reactions of primary human monocyte-derived macrophages: Perspective for personalized therapy
【24h】

Surface modification of biomaterials based on high-molecular polylactic acid and their effect on inflammatory reactions of primary human monocyte-derived macrophages: Perspective for personalized therapy

机译:基于高分子聚乳酸的生物材料的表面改性及其对原代人单核细胞衍生巨噬细胞炎症反应的影响:个性化治疗的前景

获取原文
获取原文并翻译 | 示例

摘要

Polylactic acid (PLA) based implants can cause inflammatory complications. Macrophages are key innate immune cells that control inflammation. To provide higher biocompatibility of PLA-based implants with local innate immune cells their surface properties have to be improved. In our study surface modification technique for high-molecular PLA (MW = 1,646,600 g/mol) based biomaterials was originally developed and successfully applied. Optimal modification conditions were determined. Treatment of PLA films with toluene/ethanol = 3/7 mixture for 10 min with subsequent exposure in 0.001 M brilliant green dye (BGD) solution allows to entrap approximately 10(-9) mol/cm(2) model biomolecules. The modified PLA film surface was characterized by optical microscopy, SERS, FT-IR, UV and TG/DTA/DSC analysis. Tensile strain of modified films was determined as well The effect of PLA films modified with BGD on the inflammatory reactions of primary human monocyte-derived macrophages was investigated. We developed in vitro test-system by differentiating primary monocyte-derived macrophages on a coating material. Type 1 and type 2 inflammatory cytokines (TNE alpha, CCL18) secretion and histological biomarkers (CD206, stabilin-1) expression were analyzed by ELISA and confocal microscopy respectively. BGD-modified materials have improved thermal stability and good mechanical properties. However, BGD modifications induced additional donor-specific inflammatory reactions and suppressed tolerogenic phenotype of macrophages. Therefore, our test-system successfully demonstrated specific immunomodulatory effects of original and modified PLA-based biomaterials, and can be further applied for the examination of improved coatings for implants and identification of patient-specific reactions to implants. (C) 2015 Elsevier BY. All rights reserved.
机译:基于聚乳酸(PLA)的植入物会引起炎症并发症。巨噬细胞是控制炎症的关键先天免疫细胞。为了提供具有局部先天免疫细胞的基于PLA的植入物更高的生物相容性,必须改善其表面性质。在我们的研究中,最初开发并成功地应用了基于高分子PLA(MW = 1,646,600 g / mol)的表面改性技术。确定了最佳修饰条件。用甲苯/乙醇= 3/7的混合物处理PLA膜10分钟,然后将其暴露在0.001 M亮绿色染料(BGD)溶液中,可以捕获大约10(-9)mol / cm(2)模型生物分子。通过光学显微镜,SERS,FT-IR,UV和TG / DTA / DSC分析表征改性的PLA膜表面。还确定了改性膜的拉伸应变。研究了用BGD改性的PLA膜对原代人单核细胞衍生的巨噬细胞炎症反应的影响。我们通过在涂层材料上区分原代单核细胞衍生的巨噬细胞来开发体外测试系统。通过ELISA和共聚焦显微镜分别分析了1型和2型炎性细胞因子(TNE alpha,CCL18)的分泌和组织学生物标志物(CD206,stabiin-1)的表达。 BGD改性的材料具有改善的热稳定性和良好的机械性能。但是,BGD修饰诱导额外的供体特异性炎症反应,并抑制巨噬细胞的耐受性表型。因此,我们的测试系统成功地证明了原始和改良的基于PLA的生物材料的特异性免疫调节作用,并且可以进一步用于检查改良的植入物涂层以及鉴定患者对植入物的特异性反应。 (C)2015 Elsevier BY。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号